Cosmos Health Ends 2022 with Transformed Balance Sheet and Achieves Positive Adjusted EBITDA for the Fiscal Year 2022Accesswire • 04/13/23
Cosmos Health Inc. to Participate in The Economist Annual New York-Eastern Mediterranean Business Summit on July 10th, 2023, with CEO Mr. Greg Siokas Delivering a SpeechAccesswire • 04/05/23
Cosmos Health Inc. Enters U.S. Telehealth Space with Successful Acquisition of ZipDoctor, Inc.Accesswire • 04/03/23
Cosmos Health Inc.'s UK Subsidiary Decahedron Ltd. Named Pharmaceutical Wholesaler of the Month in the Latest Issue of Healthcare MattersAccesswire • 03/24/23
Cosmos Health Inc. Enters into a Definitive Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.Accesswire • 03/17/23
Cosmos Health Enters into a Material Definitive Agreement with Cana LaboratoriesAccesswire • 03/07/23
Cosmos Health Expects to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.Accesswire • 03/03/23
Cosmos Health Extends its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.Accesswire • 02/15/23
Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid TestsAccesswire • 02/07/23
Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)PRNewsWire • 02/07/23
Cosmos Health Announces the Appointment of Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as Chief Operating OfficerAccesswire • 02/01/23
Cosmos Health Retains Christian Levine Law Group to Further Monitor Trading IrregularitiesAccesswire • 01/26/23
Cosmos Health Extends and Updates its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings CorpAccesswire • 01/20/23
Cosmos Health Provides an Update on its Debt Balance and Proforma Interest ExpenseAccesswire • 01/17/23
Cosmos Health Extends and Updates its Agreement to Acquire Cana Laboratories, a European Pharmaceutical CompanyAccesswire • 01/10/23
Cosmos Health Inc. Announces Successful Closing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-MarketAccesswire • 12/21/22
Cosmos Health stock tumbles, weighed down by $32.5 million registered direct offeringMarket Watch • 12/19/22